All In MedTech

Device Trial Radar · NCT03711643

Hypnosis Mask: a New Approach to Management of Pain in Medical Imaging

Last checked: Nov 19, 2026Latest source record: Dec 23, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

88

Actual

Start

May 7, 2019

Primary completion

Oct 26, 2021

Study completion Oct 26, 2021

Sponsor

Lead sponsor
University Hospital, LilleAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 18, 2018

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Supportive care
FDA-regulated device
No
Who can join
Male only, from 50 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The prostatic biopsies echo-guided are a painful and stressful. The purpose is to test a new medical device created recently, " Hypnos-Pro ", wich uses connected technologies. This connected device is a mask with diodes coupled with an audio headset and a touch pad. This connected mask is an another option to induce an hypnotic state for our patients. the objective is to value hypnotic mask effectiveness, to reduce the level pain and anxiety for the patients who benefit a prostatic biopsies echo-guided with local anesthesia.

Conditions

  • Prostatic Diseases

Interventions

  • Periprostatic nerve blockProcedure

    4 injections of 2 cc of lidocaine for a Periprostatic nerve block

  • hypnosis maskDevice

    The mask HYPNOS pro stimulates the imagination of the user by means of 6 diodes among 3 by eye. Just before the introduction of ultrasound probe, the patient put the hypnotic mask and choose a session.Twenty minutes after the removal of the probe, an healthworker assess the painful patient with the visual analogue scale VAS, after this the patient fulfill the STATE- TRAIT Anxiety Inventory (STAI) form Y-A.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual analogic ScaleTime frame: at 20 minutes after the removal of the probe

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hôpital Claude Huriez, CHU

    Lille, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.